Health knowledge made personal
WellPage for Antiarrhythmic
+ Bookmark › Share
Email Digg del.icio.us Reddit icon StumbleUpon Technorati
Go
Search posts:

Antiarrhythmic - Articles

STOP AF Study Shows that Cryoablation Beats Antiarrhythmic Drugs for Paroxysmal Atrial Fibrillation Treatment by Mellanie H. Patient Expert Posted Mon 15 Mar 2010 6:33am drugs to control arrhythmias. One year after treatment, 69.9% of people treated with cryoablation had no episodes of afib compared to 7.3% of those who were treated with anti-arrhythmic medications. Read more at: Study Shows Cryoablation Beats Antiarrhythmic Drugs for Treating Paroxysmal Atrial Fibrillation Read on »
STOP AF Study Shows that Cryoablation Beats Antiarrhythmic Drugs for Paroxysmal Atrial Fibrillation Treatment by Mellanie H. Patient Expert Posted Mon 15 Mar 2010 12:00am with anti-arrhythmic medications. Read more at: Study Shows Cryoablation Beats Antiarrhythmic Drugs for Treating Paroxysmal Atrial Fibrillation Read on »
Atrial Fibrillation Research Study Seeks Those Who Have Taken Antiarrhythmic Drugs by Mellanie H. Patient Expert Posted Fri 19 Jun 2009 10:10am An afib research study is looking for afib patients who are near San Francisco, Cincinnati, or New Jersey/New York and who have taken certain anti-arrhythmic medications (Flecainide, Rythmol, Propafenone, and similar). They are offering an honorarium for your time. Find out if you qualify at: Atrial Fibrillation Research Study Seeks Afib Patients near Read on »
Prof. John Camm discusses dronedarone (Multaq) and vernakalant, new antiarrhythmic drugs for atrial fibrillation -- Video by Mellanie H. Patient Expert Posted Sat 23 Jan 2010 4:21pm At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm Read on »
Prof. John Camm discusses dronedarone (Multaq) and vernakalant, new antiarrhythmic drugs for atrial fibrillation – Video by Mellanie H. Patient Expert Posted Tue 26 Jan 2010 12:00am At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm Read on »
Dr. Matthew Reynolds on Quality of Life From AF Ablation vs. Antiarrhythmic Drugs — Video by Mellanie H. Patient Expert Posted Mon 21 Mar 2011 9:00am and antiarrhythmic drugs for treatment of atrial fibrillation. He analyzed quality of life data that was collected as part of the THERMOCOOL catheter trial in which catheter ablation was found to be significantly more effective at maintaining sinus rhythm than antiarrhythmic drugs. Dr. Reynolds looked at the quality of life data collected in the trial and found that there were Read on »
How does magnesium acts as an antiarrhythmic drug ? by Dr. Sangareddi V. Medical Doctor Posted Wed 13 Jan 2010 5:57am  . And  thus , we got this  great antiarrhythmic drug ! Magnesium is a  cofactor in the enzyme Na /K ATPase in the myocyte cell membrane Integrity of this enzyme is essential Read on »
StopAfib.org applauds FDA approval of Multaq (dronedarone), a safer option to amiodarone for atrial fibrillation patient by Mellanie H. Patient Expert Posted Thu 30 Jul 2009 11:53am 1 Comment Administration (FDA) for providing a safer option for those with atrial fibrillation and atrial flutter. Dronedarone is the first new anti-arrhythmic drug approved in years for afib Read on »
The mystery drug called Ranalozine ! by Dr. Sangareddi V. Medical Doctor Posted Fri 03 Sep 2010 8:23pm the sale of the drug ! Antiarrhythmic A drug , which acts on phase  2  Na channel , it is not at all a  surprise to have anti  arrhythmic properties . It can reduce phase 2... for Ranlozine  (  4th one a real surprise !) Antianginal Anti arrhythmic Possible lusiotropic effect Anti diabetic* *It is  surprising to note Ranalozine was  reducing Hb A1 Read on »
Two UAB companies among finalists in Alabama Launchpad competition by UABNews Posted Fri 11 Mar 2011 9:34am their foundation in natural products, including medicinal plants and other botanicals. KOR Therapies will meet the market need for truly effective anti-arrhythmic drugs with protected Read on »